Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Brian Hemphill
Michael Brian Hemphill
Sarah Cannon Research Institute
Pathology
Oncology
Medicine
Internal medicine
Clinical trial
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety analysis of regorafenib prior to selective internal radiation therapy (SIRT) using 90Y resin microspheres for the treatment (tx) of patients (pts) with refractory metastatic colorectal cancer (mCRC) with liver metastases (mets).
2017
Journal of Clinical Oncology
Andrew S. Kennedy
Dianna Shipley
L. Johnetta Blakely
Michael Brian Hemphill
Kent C. Shih
Mark Mainwaring
J. D. Peyton
John D. Zubkus
David Wright
Johanna C. Bendell
Jaswinder Singh
Show All
Source
Cite
Save
Citations (0)
The Spruce clinical trial: Double-blind randomized phase II trial of carboplatin and pemetrexed +/- apatorsen in patients with previously untreated stage IV non-squamous non-small-cell lung cancer.
2016
Journal of Clinical Oncology
Dianna Shipley
David Waterhouse
Suzanne F. Jones
Dawn Michelle Stults
Patrick J. Ward
Kent C. Shih
Michael Brian Hemphill
Michael McCleod
Robert C. Whorf
Ray D. Page
Joesph Stilwell
Tarek Mekhail
Kirsten Anderson
Cindy Jacobs
John D. Hainsworth
David R. Spigel
Show All
Source
Cite
Save
Citations (1)
1